Get startedLog in
    Picture of Atara Biotherapeutics logo

    ATRA — Atara Biotherapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapMomentum Trap
    All News

    US FDA declines to approve Atara's therapy for rare blood cancer

    Picture of Atara Biotherapeutics logoAtara Biotherapeutics
    12/01/2026 13:06
    Jan 12 (Reuters) - The U.S. Food and Drug Administration on Monday declined to approve Atara Biotherapeutics' ATRA.O cell therapy for a rare form of blood cancer, the company said.

 (Reporting by Sneha S K in Bengaluru; Editing by Sahal Muhammed)

 ((Sneha.SK@thomsonreuters.com;))

    Recent news on Atara Biotherapeutics

    See all news